Gilde Healthcare exits biotech firm
Gilde Healthcare has sold Calypso Biotech to Novartis for up to $425m.
Headquartered in Amsterdam, the Netherlands, the spinout from science and tech firm Merck Calypso is a biotechnology company focused...
Gilde Healthcare has sold Calypso Biotech to Novartis for up to $425m.
Headquartered in Amsterdam, the Netherlands, the spinout from science and tech firm Merck Calypso is a biotechnology company focused...